[Therapy of hypertension. I. new antihypertensive agents, pharmacologic and pharmacokinetic bases. Beta-adrenergic blockers and blood pressure lowering].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000804:Angiotensin II / Q000378:metabolism; D000818:Animals; D001919:Bradycardia / Q000139:chemically induced; D002302:Cardiac Output / Q000187:drug effects; D002395:Catecholamines / Q000097:blood; D002415:Cats; D004285:Dogs; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007700:Kinetics; D009203:Myocardial Infarction / Q000517:prevention & control; D009638:Norepinephrine / Q000097:blood; D011311:Pressoreceptors / Q000187:drug effects; D011817:Rabbits; D012083:Renin / Q000378:metabolism; D014655:Vascular Resistance / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D000804:Angiotensin II; D012083:Renin; D009638:Norepinephrine
Therapie des Hochdrucks. I. Neue Antihypertensiva, pharmakologische und pharmakokinetische Grundlagen. Beta-Adrenerge Blocker und Blutdrucksenkung.